OpenSourceMalaria:Other GSK Series Under Consideration

From OpenWetWare

(Difference between revisions)
Jump to: navigation, search
(TCMDC 137332)
(TCMDC 137332)
Line 8: Line 8:
[[Image:TCMDC137322.png|thumb|center|540px|Scheme 1: TCMDC 137332]] <br>
[[Image:TCMDC137322.png|thumb|center|540px|Scheme 1: TCMDC 137332]] <br>
 +
InChI=1S/C17H18ClNO2/c1-17(2,3)16(20)19-14-6-4-5-7-15(14)21-13-10-8-12(18)9-11-13/h4-11H,1-3H3,(H,19,20)
 +
ClC(C=C1)=CC=C1OC2=CC=CC=C2NC(C(C)(C)C)=O
Citations for exact structure search:
Citations for exact structure search:
Line 20: Line 22:
ComGenex Compound (Scheme 2)
ComGenex Compound (Scheme 2)
[[Image:ComGenex.png|thumb|center|540px|Scheme 2: ComGenex Compound]] <br>
[[Image:ComGenex.png|thumb|center|540px|Scheme 2: ComGenex Compound]] <br>
 +
InChI=1S/C17H17Cl2NO2/c1-17(2,3)16(21)20-13-6-4-5-7-15(13)22-14-9-8-11(18)10-12(14)19/h4-10H,1-3H3,(H,20,21)
 +
ClC(C=C1)=CC(Cl)=C1OC2=CC=CC=C2NC(C(C)(C)C)=O

Revision as of 20:51, 12 May 2013

Malaria Home        OSM So Far        Compound Series        Links        Open Source Research Home        Tech Ops        FAQ       


Other GSK Series Under Consideration

The team have focused on the synthesis and evaluation of two series (the aryl pyrroles and aminothienopyrimidines) to date. The focus of the project could change quite rapidly following the receipt of new biological data (for highly active or inactive compounds). This page highlights other GSK compounds from the TCAMS data that look attractive.

TCMDC 137332

Scheme 1: TCMDC 137332
Scheme 1: TCMDC 137332

InChI=1S/C17H18ClNO2/c1-17(2,3)16(20)19-14-6-4-5-7-15(14)21-13-10-8-12(18)9-11-13/h4-11H,1-3H3,(H,19,20) ClC(C=C1)=CC=C1OC2=CC=CC=C2NC(C(C)(C)C)=O

Citations for exact structure search: DOI:10.1021/ml200135p – GSK Paper on Open Innovation WO 1994-GB1409 – Preparation of anti-atherosclerotic1diaryl compound, The Wellcome Foundation

InChi Search: No hits on Google

Citations for sub-structure search: WO 2000-EP1224 – Preparation of phenyl and pyridinyl derivatives as NK-1 receptor antagonists, 2 F. Hoffmann La Roche ComGenex Compound (Scheme 2)

Scheme 2: ComGenex Compound
Scheme 2: ComGenex Compound

InChI=1S/C17H17Cl2NO2/c1-17(2,3)16(21)20-13-6-4-5-7-15(13)22-14-9-8-11(18)10-12(14)19/h4-10H,1-3H3,(H,20,21) ClC(C=C1)=CC(Cl)=C1OC2=CC=CC=C2NC(C(C)(C)C)=O

Personal tools